✦ LIBER ✦

Disseminated herpes simplex virus infection following epidermal growth factor tyrosine kinase inhibitor therapy for non-small-cell lung carcinoma

✍ Scribed by Teh, B. W.; Worth, L. J.

Book ID: 119844624
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 115 KB
Volume: 42
Category: Article
ISSN: 1444-0903
DOI: 10.1111/j.1445-5994.2012.02956.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients

✍ Roengvoraphoj, Monic; Tsongalis, Gregory J.; Dragnev, Konstantin H.; Rigas, Jame 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 695 KB

A review of small-molecule epidermal gro

A review of small-molecule epidermal growth factor receptor-specific tyrosine kinase inhibitors in development for non-small cell lung cancer

✍ Katrina Y Glover; Roman Perez-Soler; Vassiliki A Papadimitradopoulou 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

✍ K. Bencardino; M. Manzoni; S. Delfanti; A. Riccardi; M. Danova; G. R. Corazza 📂 Article 📅 2007 🏛 Springer Milan 🌐 English ⚖ 117 KB

KRAS Mutation Is an Important Predictor

KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer

✍ Massarelli, E.; Varella-Garcia, M.; Tang, X.; Xavier, A. C.; Ozburn, N. C.; Liu, 📂 Article 📅 2007 🏛 American Association for Cancer Research 🌐 English ⚖ 196 KB

Oral epidermal growth factor receptor ty

Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: Comparative pharmacokinetics and drug–drug interactions

✍ Peters, Solange; Zimmermann, Stefan; Adjei, Alex A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Erlotinib (OSI-774, Tarceva™), a Selecti

Erlotinib (OSI-774, Tarceva™), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Chemotherapy for Advanced Non–Small-Cell Lung Cancer

✍ Mary Hightower; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 78 KB